Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis.
about
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortalityHemophagocytic syndrome: an unusual and underestimated complication of cytoreduction surgery with heated intraperitoneal oxaliplatin.Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy.Prospective randomized trial evaluating mandatory second look surgery with HIPEC and CRS vs. standard of care in patients at high risk of developing colorectal peritoneal metastases.Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases.Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasmsPharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats.A comparison of hematologic toxicity profiles after heated intraperitoneal chemotherapy with oxaliplatin and mitomycin C.Hepatic necrosis and hemorrhage following hyperthermic intraperitoneal chemotherapy with oxaliplatin: A review of two cases.Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer.Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery.Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesothelioma.Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.Optimization of drug delivery systems for intraperitoneal therapy to extend the residence time of the chemotherapeutic agent.
P2860
Q26768309-D3BC4C77-9160-439F-9BDF-F2D828FC8F3AQ33408999-8FD2BEB1-F502-4131-B2C0-D96075EC1861Q33416610-78A69CA2-D78E-4140-A4D3-094AEF5F7F9BQ33931049-D0B6C68A-FE8C-4508-8ECD-E9649A6B8305Q34003396-B8BC018C-05F2-4922-A1E6-7B11822E2DF4Q35445073-F690ACB0-98B5-4B5D-A1B8-B9A2FC7AE728Q37245482-ACEA3AA2-5CD0-41BA-B1BB-167133E74DE9Q37597149-800B097F-2E25-431E-A80F-3763C413FA57Q38027521-4B64FB0A-FA03-4EE9-9303-098DDE90A880Q41132998-30802478-59DC-4671-B5CE-3D9A0380CB67Q50111382-38AC1974-7DA3-49C2-9C33-3345EAA588F2Q52866005-EFA91A04-D6EA-45D9-9ABE-9539B7E7B1F4Q52952846-ADA8FDEF-5092-47CD-BD54-2B16ECA5584DQ55135995-98ED863E-ABAA-4511-BD94-696802FEB097
P2860
Human pharmacokinetic study of heated intraperitoneal oxaliplatin in increasingly hypotonic solutions after complete resection of peritoneal carcinomatosis.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Human pharmacokinetic study of ...... of peritoneal carcinomatosis.
@ast
Human pharmacokinetic study of ...... of peritoneal carcinomatosis.
@en
type
label
Human pharmacokinetic study of ...... of peritoneal carcinomatosis.
@ast
Human pharmacokinetic study of ...... of peritoneal carcinomatosis.
@en
prefLabel
Human pharmacokinetic study of ...... of peritoneal carcinomatosis.
@ast
Human pharmacokinetic study of ...... of peritoneal carcinomatosis.
@en
P2093
P356
P1433
P1476
Human pharmacokinetic study of ...... n of peritoneal carcinomatosis
@en
P2093
A El Otmany
P304
P356
10.1159/000066229
P50
P577
2002-01-01T00:00:00Z